Balyasny Asset Management
MNTA

Balyasny Asset Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Balyasny Asset Management’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-700,000
Closed -$36.7M – 1884
2020
Q3 		$36.7M Buy
+700,000
New +$29M 0.27% 79

Balyasny Asset Management's MNTA Position: Q4 2020 in Review

Balyasny Asset Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 1,069,013 shares — an estimated $56.1M sold.

Balyasny Asset Management first reported a position in MNTA in Q3 2013 and held it in 10 quarters. The position peaked at $56.1M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

  • Balyasny Asset Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • Balyasny Asset Management sold 1,069,013 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $56.1M.
  • Balyasny Asset Management first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2013 and held it in 10 quarters.
  • Balyasny Asset Management's Momenta Pharmaceuticals, Inc. position peaked at $56.1M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Balyasny Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.